Drug
Tasisulam sodium clinical trials
Also written LY573636.
A product of Tasisulam; its studies count on that page too.
- studies test it
- 8
- open now
- 0
- in phase 3
- 1
- first study started
- 2006
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
8 studies that test it; most in 2009 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 4
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses tasisulam sodium is read from its arms, and is right about nine times in ten.
Testing it · 8
- A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue SarcomaCompletedPhase 2Eli Lilly and CompanyNCT00490451Written as LY573636-sodium
- A Phase 1b Trial in Patients With Renal Cell CancerCompletedPhase 1Eli Lilly and CompanyNCT01258348Written as Drug: LY573636-sodium
- Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid LeukemiaCompletedPhase 1Eli Lilly and CompanyNCT00718159Written as LY573636-sodium
- Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid TumorsCompletedPhase 1Eli Lilly and CompanyNCT01214668Written as LY573636-sodium
- Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung CancerCompletedPhase 2Eli Lilly and CompanyNCT00363766Written as LY573636-sodium
- A Study of LY573636-sodium in Patients With Metastatic Breast CancerCompletedPhase 2Eli Lilly and CompanyNCT00992225Written as LY573636-sodium
- A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic MelanomaTerminatedPhase 3Eli Lilly and CompanyNCT01006252Written as Tasisulam-sodium
- A Study of Chemotherapy Treatment for Patients With Ovarian CancerCompletedPhase 2Eli Lilly and CompanyNCT00428610Written as LY573636-sodium
Codes
What other systems call tasisulam sodium · ClinicalTrials.gg INT017446
- UNII (FDA) O3955SHR9JTASISULAM SODIUMConfirmed FDA, Wikidata
- Wikidata Q27285273tasisulam sodiumConfirmed FDA, Wikidata
- NCI Thesaurus C88304Tasisulam SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | O3955SHR9J | TASISULAM SODIUM | Confirmed FDA, Wikidata |
| Wikidata | Q27285273 | tasisulam sodium | Confirmed FDA, Wikidata |
| NCI Thesaurus | C88304 | Tasisulam Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.